跳至主要内容
临床试验/DRKS00012578
DRKS00012578
已完成
4 期

Auricular Vagal Nerve Stimulation in Peripheral Arterial Disease - STIVAX Trial

Angiologie, Meduni Graz0 个研究点目标入组 40 人2017年7月27日

概览

阶段
4 期
干预措施
未指定
疾病 / 适应症
I70.2
发起方
Angiologie, Meduni Graz
入组人数
40
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2017年7月27日
结束日期
2016年9月30日
最后更新
去年
研究类型
Interventional
性别
All

研究者

发起方
Angiologie, Meduni Graz

入排标准

入选标准

  • Inclusion criteria were a written informed consent and a lifestyle\-limiting PAOD due to calf\-pain in Fontaine\-stage IIb existing for at least 6 months. Furthermore, at least one hemodynamically relevant vascular obstruction or vascular occlusion in the arterial femoropopliteal area had to be verified with radiological imaging (MR\-Angiography, CT\-Angiography, Colour coded Duplex Sonography or Digital Subtraction Angiography).

排除标准

  • Relevant exclusion criteria were a known symptomatic diabetic polyneuropathy, claudicatio spinalis, atrial fibrillation, therapy with prostanoids within the last 6 months, structured exercise training within the last 6 months, myocardial infarction within the last 6 months, stroke / transitory ischemic attack within the last 6 months, pregnancy, any kind of paralyses of the limbs, other implanted devices (pacemaker, implanted cardioverter defibrillator, cardiac resynchronization therapy, implanted analgesics pump) as well as a known malignant neoplasia. Moreover, patients were not included in the trial if the walking distance was anamnestically limited by other causes than intermittent claudication (e.g. dyspnoea or chest pain).

结局指标

主要结局

未指定

相似试验